Implanted Lens for Post-Surgery Adjustment Snags FDA Approval
RxSight received the FDA’s approval for the first medical device system that allows for artificial lens adjustments post-cataract surgery with UV light-reacting material.
The system consists of the firm’s light adjustable lens and light delivery device. It was designed to eliminate the need for glasses, contact lenses or an additional surgery to address blurred vision after cataract surgery performed to replace an astigmatic patient’s natural lenses with an artificial lens.
The system allows the physician to make small adjustments to the implanted lens during several in-office procedures after the initial surgery.